Literature DB >> 6467498

Penetration and binding of vinblastine and 5-fluorouracil in cellular spheroids.

T Nederman, J Carlsson.   

Abstract

The kinetics of the penetration and binding of the two commonly used antitumour drugs vinblastine and 5-fluorouracil in nonvascularized tumour tissue were studied. Multicellular human tumour spheroids (glioma U-118 MG and thyroid cancer HTh-7) were used as a model system. Radiolabelled drugs were used in all studies. To avoid disturbances in the distribution of unbound drugs a dry histological technique was used in combination with contact autoradiography. In addition, quantitative measurements of the accumulation and binding of the drugs were made. The results showed that vinblastine penetrated the spheroids less efficiently than 5-fluorouracil. Vinblastine required about 2 h to be isotropically distributed within the studied spheroids, while only a few minutes were required for 5-fluorouracil. Vinblastine seemed to be accumulated in the peripheral parts of the spheroids within 15 min. High concentrations of 5-fluorouracil, isotropically distributed in the spheroids, were observed after 2 h of incubation. Significant amounts (about half) of the accumulated drugs resisted gentle washing for 3 X 20 s plus 15 min in fresh medium. The limited penetration of vinblastine correlated well with a previously observed high resistance of spheroids to treatments of short duration with this drug.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6467498     DOI: 10.1007/bf00257130

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  19 in total

1.  Understanding the actions of carcinostatic drugs to improve chemotherapy: 5-fluorouracil.

Authors:  H G Mandel; P Klubes; D J Fernandes
Journal:  Adv Enzyme Regul       Date:  1977 Oct 3-4

2.  Pharmacokinetics and metabolism of vinblastine in humans.

Authors:  R J Owellen; C A Hartke; F O Hains
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

3.  [Chemistry and mode of action of vinca alkaloids].

Authors:  K Wilms
Journal:  Planta Med       Date:  1972-11       Impact factor: 3.352

4.  Effects of vinblastine and 5-fluorouracil on human glioma and thyroid cancer cell monolayers and spheroids.

Authors:  T Nederman
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

5.  Demonstration of an extracellular matrix in multicellular tumor spheroids.

Authors:  T Nederman; B Norling; B Glimelius; J Carlsson; U Brunk
Journal:  Cancer Res       Date:  1984-07       Impact factor: 12.701

6.  Flow cytometry studies of intracellular adriamycin in multicell spheroids in vitro.

Authors:  R E Durand
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

7.  Limited penetration of methotrexate into human osteosarcoma spheroids as a proposed model for solid tumor resistance to adjuvant chemotherapy.

Authors:  G W West; R Weichselbaum; J B Little
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

8.  Accumulation and release of vinblastine and vincristine by HeLa cells: light microscopic, cinematographic, and biochemical study.

Authors:  A M Lengsfeld; J Dietrich; B Schultze-Maurer
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

9.  Pharmacokinetics of fluorouracil in humans.

Authors:  W E MacMillan; W H Wolberg; P G Welling
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

10.  Resistance to vincristine of human cells grown as multicellular spheroids.

Authors:  E Wibe
Journal:  Br J Cancer       Date:  1980-12       Impact factor: 7.640

View more
  21 in total

Review 1.  Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics.

Authors:  Csilla Hasovits; Stephen Clarke
Journal:  Clin Pharmacokinet       Date:  2012-04-01       Impact factor: 6.447

Review 2.  Intraperitoneal drug delivery of antineoplastics.

Authors:  M Markman
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Novel in vitro model barriers for evaluation of the permeability of antitumor compounds, thioxanthones.

Authors:  Venugopal Marasanapalle; Xiaoling Li; Lisa Polin; Bhaskara R Jasti
Journal:  Invest New Drugs       Date:  2006-03       Impact factor: 3.850

Review 4.  Drug and radiation resistance in spheroids: cell contact and kinetics.

Authors:  P L Olive; R E Durand
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

5.  Multicellular membranes as an in vitro model for extravascular diffusion in tumours.

Authors:  D S Cowan; K O Hicks; W R Wilson
Journal:  Br J Cancer Suppl       Date:  1996-07

6.  Relations between the penetration, binding and average concentration of cytostatic drugs in human tumour spheroids.

Authors:  M Erlanson; E Daniel-Szolgay; J Carlsson
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 7.  Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence.

Authors:  Wim P Ceelen; Michael F Flessner
Journal:  Nat Rev Clin Oncol       Date:  2009-12-15       Impact factor: 66.675

Review 8.  Drug delivery and transport to solid tumors.

Authors:  Seong Hoon Jang; M Guillaume Wientjes; Dan Lu; Jessie L S Au
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

Review 9.  Drug distribution in tumors: mechanisms, role in drug resistance, and methods for modification.

Authors:  Antonello Di Paolo; Guido Bocci
Journal:  Curr Oncol Rep       Date:  2007-03       Impact factor: 5.075

10.  Toxicity of 5-fluorouracil for aerobic and hypoxic cells in two murine tumours.

Authors:  I F Tannock
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.